Menu
Washingtoner
  • Home
  • Boeing
  • Technology
  • Daryl Guberman
  • Aerospace
  • Health
  • ANSI-ANAB
  • Financial
  • Business
Washingtoner

FreezeNit Announces Exclusive Licensing of Novel Non-Toxic Lice Treatment Technology
Washingtoner/10287890

Trending...
  • Acuvance Appoints Sandeep Sabharwal to Board of Directors, Strengthening Leadership to Support Continued Platform Growth
  • Grange Insurance Association to Rebrand as Granwest Insurance on July 1, 2026
  • Hazel E Hosts Starline Tours Bus to Sonic Desert - A Launch to Coachella
FreezeNit
Naturally-Derived OTC Gel Eliminates Lice Without Neurotoxins, Launching Spring 2025

MARBLEHEAD, Mass. - Washingtoner -- FreezeNit, a leader in innovative lice treatment solutions, is thrilled to announce the exclusive licensing of a novel over-the-counter (OTC) lice treatment gel designed to provide a safe, naturally-derived, and highly effective alternative to traditional synthetic or pesticide-based lice treatments.

Unlike conventional OTC lice treatments that rely on pesticide-based pyrethroids, which have decreasing efficacy due to lice resistance, this new technology works by a purely mechanical method of action to eliminate lice and their eggs. The patented formula is free from harsh chemicals and instead leverages natural abrasives, such as diatomaceous earth and walnut shell powder, orange oil extract, and conditioning agents to physically shred lice and nits, while being gentle on the hair and scalp.

This addition strengthens FreezeNit's growing product portfolio, reinforcing the company's mission to provide clean, effective, science-backed treatments that parents can trust.

"This is an incredibly exciting milestone for FreezeNit," said Joanna Shu, CEO of FreezeNit. "By securing exclusive rights to this novel technology, we're positioned to be on the cutting edge of first aid treatments that are gentle on kids. Traditional lice treatments have failed parents and kids, but with this gel, lice don't stand a chance."

More on Washingtoner
  • The New World of Freight Brokering with AI
  • Captain Notepad Launches Full-Service Direct Mail Platform for Small Businesses Nationwide
  • World Cup Buzz Fuels Nayarit's Rise as Mexico's Pacific Standout
  • Nayarit strengthens its position in Mexico's Culinary Elite with 8 restaurants in the 2026 Mexico Gastronomic Guide
  • Winter Garden Ski Lake Home Sells for $2.05M in Cash Transaction, Highlighting Demand for Strategically Positioned Luxury Properties

✔ Clinically Proven – was shown to be 96% effective in a clinical trial.
✔ No Resistance Issues – Unlike permethrin-based treatments, which have seen increased lice resistance, this technology works mechanically—not chemically—so lice cannot develop immunity.
✔ Patented & Protected – This novel formula and method of action is patented in the U.S., Canada, and the EU, ensuring exclusivity in the market.
✔ Class I, 510(k) Exempt – The FDA-regulated status allows for a fast-tracked market entry.

FreezeNit is actively engaging with retailers, distributors, and healthcare providers to bring this breakthrough lice treatment to families everywhere.

FreezeNit is an innovative healthcare company dedicated to revolutionizing first-aid with safe, effective, and science-backed solutions. By leveraging cutting-edge technology and natural alternatives to neurotoxins, FreezeNit provides families with fast, reliable, and pesticide-free treatments for head lice infestations.  For more information, visit www.FreezeNit.com.

Media Contact
Cathy Henry
cathy@freezenit.com
214-924-5992


Source: FreezeNit

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Peernovation And Inception Stratos Launch Joint Venture To Build A Global Peer-powered Performance Platform
  • GDE Tree Services Expands Operations Across Logan, Ipswich and the Gold Coast
  • UK AltNet FullFibre Solves IPv4 Shortage With netElastic BNG And CGNAT Networking Software
  • Tacoma: Applicants Sought for the Equity in Contracting Advisory Committee
  • Tacoma: Hylebos Bridge Closed to Vehicular Traffic
  • Studica Robotics Receives 2026 Partner Excellence Award from FIRST® Robotics Canada
  • Seven Games That Make You Think (and Smile) Earn 2026 Mensa Select® Honors
  • The Ramen Rater Unveils Top Ten Instant Noodles Of All Time – 2026 Edition
  • New Research Reveals Gen Z Trusts Independent Sources Over Influencers — Exposing What We are Talker Calls "The Independent Validation Gap"
  • City of Tacoma's Public Works Department Recognized by American Public Works Association
  • New research identifies The Discovery Gap: Seven in 10 Americans say travel is no longer just about getting away
  • PropAccount.com Adds Equities to Its Multi-Asset Prop Firm Platform, Opening the Door to the World's Largest Trading Market
  • Ailias Launches Global Partner Programme for AI-Powered Conversational Digital Humans in Events and Experiences
  • Village People Headline "Rock The Rainbow" Phuket Pride Finale 2026
  • SilverBow Strategies Launches RFPArchon™, the First Product in Its Artemis AI Solutions™ Suite
  • Sawasdee Anime Launches Animenture: A Gamified SNS Connecting Global Fans to 2,000+ Anime Sites
  • "LOOK UP CAFE TOKYO SKYTREE" to Open on May 22, 2026 on the 5th floor of TOKYO SKYTREE®. This Date also Marks TOKYO SKYTREE's 14th Anniversary
  • "Rehabilitative Prison Program Compromised by Alleged Staff Misconduct, Whistleblower Claims"
  • Creator Space LA brings together industry leaders for an immersive AI showcase, demonstrations, and film hackathon
  • The Hardest Part of Building an App Isn't Starting - It's Finishing
_catLbl0 _catLbl1

Popular on Washingtoner

  • Registered Nurse Launches Healthcare Wealth Strategy Practice for Healthcare Professionals - 640
  • A Letter From the Tacoma City Council to the Sound Transit Board
  • Foiling Freaks Launches New Online Platform Dedicated to Foiling Board Sports
  • Monexplora Explains the Options Mechanics Behind March's Tech Selloff and VIX Surge
  • Mensa Brings National Board Game Competition to Northern Virginia April 16-19
  • Tacoma: Lincoln Avenue Bridge to Close Saturday, April 18 for Asphalt Repairs
  • City Council to Discuss ‘Connect Tacoma’ Transportation Levy Replacement at April 14 Study Session
  • KeysCaribbean Offers 'Skip-the-Crowds' Savings With 15 Percent Off April Stays
  • Spokane: Call for High School Artists: 2026 Riverfront Park Poster Contest
  • Attorney Joseph C. Kreps Files Lawsuit to Stop Alabama State Board of Pharmacy's Unlawful "Revenue-First" Rulemaking

Similar on Washingtoner

  • "Fearless and Free": Long Beach Pride 2026 Celebrates Resilience, Family, and Multicultural Connection
  • Deborah E. Jones Releases Emotional Sovereignty, a Book on Emotional Awareness and Self-Regulation
  • Strobert Tree Services' "50 Shades of Green" Campaign Encourages Arbor Day Action Across Delaware and Pennsylvania
  • As Fluoride Debate Grips the Nation, Americans Turn to Whole-House Fluoride Filters for Answers
  • Presidential Acceleration of Psychedelic Therapies Enters a Defining Moment as Federal Policy, FDA Alignment & Breakthrough Neurotechnology Converge
  • Peernovation And Inception Stratos Launch Joint Venture To Build A Global Peer-powered Performance Platform
  • Seven Games That Make You Think (and Smile) Earn 2026 Mensa Select® Honors
  • New research identifies The Discovery Gap: Seven in 10 Americans say travel is no longer just about getting away
  • Ailias Launches Global Partner Programme for AI-Powered Conversational Digital Humans in Events and Experiences
  • "Rehabilitative Prison Program Compromised by Alleged Staff Misconduct, Whistleblower Claims"
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute